Show simple item record

SOX2 Expression Is an Independent Predictor of Oral Cancer Progression

dc.contributor.authorde Vicente, Juan C. 
dc.contributor.authorDonate-Pérez del Molino, Paula
dc.contributor.authorRodrigo Tapia, Juan Pablo 
dc.contributor.authorAllonca Campa, Eva 
dc.contributor.authorHermida Prado, Francisco José 
dc.contributor.authorGranda Díaz, Rocío 
dc.contributor.authorRodríguez Santamarta, Tania 
dc.contributor.authorGarcía Pedrero, Juana María 
dc.date.accessioned2020-04-29T10:56:08Z
dc.date.available2020-04-29T10:56:08Z
dc.date.issued2019
dc.identifier.citationJournal Of Clinical Medicine, 8(10), p. 1744- (2019); doi:10.3390/jcm8101744
dc.identifier.urihttp://hdl.handle.net/10651/54385
dc.description.sponsorshipThis study was supported by grants from the Plan Nacional de I+D+I 2013-2016 ISCIII PI16/00280 and CIBERONC (CB16/12/00390), Fundación Merck Salud (17-CC-008), the Instituto de Investigación Sanitariadel Principado de Asturias (ISPA), PCTI-Asturias (GRUPIN14-003), Fundación Bancaria Caja de Ahorros de Asturias-IUOPA, and the FEDER Funding Program from the European Union.
dc.format.extentp. 1744-
dc.language.isoeng
dc.relation.ispartofJournal Of Clinical Medicine, 8
dc.rights© 2019 de Vicente et al.
dc.rightsCC Reconocimiento 4.0 Internacional
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceWOS:000498398500242
dc.titleSOX2 Expression Is an Independent Predictor of Oral Cancer Progression
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/jcm8101744
dc.type.dcmitext
dc.relation.projectIDGRUPIN14-003
dc.relation.projectIDSCIII/PI16/00280
dc.relation.projectIDCIBERONC/CB16/12/00390
dc.relation.publisherversionhttp://dx.doi.org/10.3390/jcm8101744
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess


Files in this item

untranslated

This item appears in the following Collection(s)

Show simple item record

© 2019 de Vicente et al.
This item is protected with a Creative Commons License